Scott C. Brun, MD

Scott is currently the head of Gold Mast Consulting, where he provides technical advice and strategic guidance related to biopharmaceutical research and development as well as pipeline and [...]

Sakae Asanuma

Sakae Asanuma founded Taiho Ventures in 2016, the corporate venture-arm of Taiho Pharmaceutical. Prior to joining Taiho, he was President and CEO at Astellas Venture Management as well as US Head [...]

Eric de La Fortelle, PH.D.

Eric is a Venture Partner with Seventure Partners, a Paris-based venture capital firm investing broadly in life sciences (Rx, Dx, medical device) with a specific focus on the human microbiome. [...]

Ronald C. Renaud

Ron has served as Translate Bio’s chief executive officer since 2014. Formerly, Ron was at Idenix Pharmaceuticals (2007-2014), where he served as chief financial officer, chief business officer [...]

Sarkis Mazmanian, Ph.D.

Sarkis K Mazmanian, PhD, is the Luis & Nelly Soux Professor of Microbiology in the Division of Biology & Biological Engineering at the California Institute of Technology (Caltech). He is [...]

Rich Aldrich

Mr. Aldrich is a co-founder and Partner of Longwood Fund. He has co-founded and helped to build several successful biotech companies including Vertex Pharmaceuticals (NASDAQ: VRTX), Sirtris [...]

A. Stewart Campbell, Ph.D.

Dr. Campbell joined Axial in 2016 and was appointed the company’s CEO in February 2021. Dr. Campbell has played a fundamental role in company’s growth and strategy over the last 4 years. He [...]

Jim Blair, Ph.D.

Jim has been a partner of Domain since its inception in 1985.  Jim has more than 45 years of experience with venture and emerging growth companies. In the course of his experience, he has been [...]